Literature DB >> 16937473

Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model.

Cagatay Korkut1, Oktar Asoglu, Murat Aksoy, Yersu Kapran, Hatice Bilge, Nese Kiremit-Korkut, Mesut Parlak.   

Abstract

AIM: To evaluate the prevalent topical therapeutic modalities available for the treatment of acute radiation proctitis compared to formalin.
METHODS: A total of 120 rats were used. Four groups (n = 30) were analyzed with one group for each of the following applied therapy modalities: control, mesalazine, formalin, betamethasone, and misoprostol. A single fraction of 17.5 Gy was delivered to each rat. The rats in control group rats were given saline, and the rats in the other three groups received appropriate enemas twice a day beginning on the first day after the irradiation until the day of euthanasia. On d 5, 10, and 15, ten rats from each group were euthanized and a pathologist who was unaware of treatment assignment examined the rectums using a scoring system.
RESULTS: The histopathologic scores for surface epithelium, glands (crypts) and lamina propria stroma of the rectums reached their maximum level on d 10. The control and formalin groups had the highest and mesalazine had the lowest, respectively on d 10. On the 15th d, mesalazine, betamethasone, and misoprostol had the lowest scores of betamethasone.
CONCLUSION: Mesalazine, betamethasone, and misoprostol are the best topical agents for radiation proctitis and formalin has an inflammatory effect and should not be used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937473      PMCID: PMC4087625          DOI: 10.3748/wjg.v12.i30.4879

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Medical therapy for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

2.  Prevention and therapy of radiation-induced bowel discomfort.

Authors:  R Henriksson; L Franzén; B Littbrand
Journal:  Scand J Gastroenterol Suppl       Date:  1992

3.  Endoluminal formalin therapy for haemorrhagic radiation proctitis.

Authors:  V Mathai; F Seow-Choen
Journal:  Br J Surg       Date:  1995-02       Impact factor: 6.939

4.  Late GI and GU complications in the treatment of prostate cancer.

Authors:  T E Schultheiss; W R Lee; M A Hunt; A L Hanlon; R S Peter; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-01       Impact factor: 7.038

5.  A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients.

Authors:  A M Khan; J W Birk; J C Anderson; M Georgsson; T L Park; C J Smith; G M Comer
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

6.  Metronidazole in the treatment of chronic radiation proctitis: clinical trial.

Authors:  J Cavcić; J Turcić; P Martinac; Z Jelincić; B Zupancić; R Panijan-Pezerović; J Unusić
Journal:  Croat Med J       Date:  2000-09       Impact factor: 1.351

7.  The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).

Authors:  C J Wang; S W Leung; H C Chen; L M Sun; F M Fang; E Y Huang; C Y Hsiung; C C Changchien
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

Review 8.  Radiation proctitis. Clinical and pathological manifestations, therapy and prophylaxis of acute and late injurious effects of radiation on the rectal mucosa.

Authors:  F B Zimmermann; H J Feldmann
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

9.  A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis.

Authors:  C A Baughan; P A Canney; R B Buchanan; R M Pickering
Journal:  Clin Oncol (R Coll Radiol)       Date:  1993       Impact factor: 4.126

10.  Distribution of mesalazine enemas in active and quiescent ulcerative colitis.

Authors:  A A van Bodegraven; R O Boer; J Lourens; H A Tuynman; J W Sindram
Journal:  Aliment Pharmacol Ther       Date:  1996-06       Impact factor: 8.171

View more
  5 in total

1.  The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats.

Authors:  Özgür Dandin; Mehmet Levhi Akin; Ahmet Ziya Balta; Ergün Yücel; Dursun Özgür Karakaş; Sezai Demirbaş; Sevim Özdemir; Apdullah Haholu
Journal:  Indian J Surg       Date:  2013-05-05       Impact factor: 0.656

2.  Safety and efficacy of Qingre Buyi Decoction in the treatment of acute radiation proctitis: a prospective, randomized and controlled trial.

Authors:  Lie Wang; Zai-zhong Zhang; Xiao-huang Tu; Zhong-dong Zou; Jian-hua Liu; Yu Wang
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

3.  Effects of ozonated olive oil on acute radiation proctitis in rats.

Authors:  Fatma Ayça Gültekin; Bekir Hakan Bakkal; Demet Sümer; Füruzan Köktürk; Sibel Bektaş
Journal:  Balkan Med J       Date:  2013-12-01       Impact factor: 2.021

4.  Low-Dose Aspirin Therapy Does not Increase the Severity of Acute Radiation Proctitis.

Authors:  Hiroshi Doi; Norihiko Kamikonya; Yasuhiro Takada; Yasue Niwa; Masayuki Fujiwara; Keita Tsuboi; Hideharu Miura; Hiroyuki Inoue; Masao Tanooka; Takeshi Nakamura; Toshiyuki Shikata; Takeshi Kimura; Tohru Tsujimura; Shozo Hirota
Journal:  World J Oncol       Date:  2012-08-26

5.  Novel mechanisms underlying inhibition of inflammation-induced angiogenesis by dexamethasone and gentamicin via PI3K/AKT/NF-κB/VEGF pathways in acute radiation proctitis.

Authors:  Yousong Li; Qin Ding; Jinsheng Gao; Chunxia Li; Pengxiao Hou; Jie Xu; Kaiqi Cao; Min Hu; Lin Cheng; Xixing Wang; Xiaoling Yang
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.